Elevance Book Value Per Share from 2010 to 2025

ELV Stock

USD 430.53 7.06 1.67%

Elevance Health Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Elevance Health according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

182.10856138

Current Value

191.21

Quarterly Volatility

47.4190377

Credit Downgrade

Yuan Drop

Covid

Check Elevance Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevance Health's main balance sheet or income statement drivers, such as Interest Expense of 1.2 B, Total Revenue of 185.7 B or Gross Profit of 164.9 B, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0156 or PTB Ratio of 1.51. Elevance financial statements analysis is a perfect complement when working with Elevance Health Valuation or Volatility modules.

Check out the analysis of Elevance Health Correlation against competitors.

For more information on how to buy Elevance Stock please use our How to Invest in Elevance Health guide.

Latest Elevance Health's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Elevance Health over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Elevance Health's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevance Health's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 181.62 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Elevance Book Value Per Share Regression Statistics

	Arithmetic Mean	114.22
	Geometric Mean	97.93
	Coefficient Of Variation	41.52
	Mean Deviation	37.37
	Median	112.23
	Standard Deviation	47.42
	Sample Variance	2,249
	Range	183
	R-Value	0.97
	Mean Square Error	160.56
	R-Squared	0.93
	Slope	9.62
	Total Sum of Squares	33,728

Elevance Book Value Per Share History

	2025	191.21
	2024	182.11
	2023	169.07
	2022	151.38
	2021	148.19
	2020	132.37
	2019	124.18

Other Fundumenentals of Elevance Health

Tangible Book Value Per Share

Elevance Health Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Liab	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Intangible Assets	Property Plant Equipment	Net Receivables	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Good Will	Deferred Long Term Liab	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Capital Stock
Total Assets		0.99	0.78	0.85	0.83	0.84	0.79	0.96	0.92	0.8	0.74	0.95	0.61	-0.03	0.78	0.98	0.38	0.27	0.96	-0.7	0.68	-0.01	0.75	0.73	-0.65
Total Stockholder Equity	0.99		0.78	0.84	0.82	0.8	0.79	0.96	0.95	0.78	0.71	0.9	0.63	0.11	0.82	0.98	0.4	0.22	0.94	-0.69	0.63	-0.05	0.69	0.68	-0.59
Net Debt	0.78	0.78		0.95	0.92	0.92	0.98	0.7	0.82	0.9	0.89	0.75	0.54	0.03	0.87	0.85	0.51	0.25	0.83	-0.87	0.72	0.09	0.58	0.74	-0.7
Total Liab	0.85	0.84	0.95		0.99	0.98	0.98	0.8	0.82	0.97	0.93	0.82	0.5	-0.07	0.86	0.87	0.38	0.38	0.9	-0.84	0.84	0.01	0.74	0.85	-0.82
Retained Earnings	0.83	0.82	0.92	0.99		0.98	0.97	0.78	0.76	0.99	0.95	0.83	0.53	-0.14	0.79	0.84	0.28	0.5	0.91	-0.8	0.87	-0.03	0.77	0.88	-0.83
Accounts Payable	0.84	0.8	0.92	0.98	0.98		0.96	0.78	0.75	0.97	0.93	0.88	0.46	-0.2	0.78	0.85	0.4	0.48	0.89	-0.81	0.85	0.01	0.76	0.85	-0.82
Long Term Debt	0.79	0.79	0.98	0.98	0.97	0.96		0.71	0.79	0.96	0.92	0.78	0.48	-0.05	0.85	0.84	0.43	0.36	0.86	-0.86	0.78	0.05	0.68	0.82	-0.77
Short Term Investments	0.96	0.96	0.7	0.8	0.78	0.78	0.71		0.89	0.74	0.67	0.89	0.52	0.04	0.78	0.93	0.36	0.21	0.9	-0.61	0.67	-0.03	0.69	0.66	-0.62
Intangible Assets	0.92	0.95	0.82	0.82	0.76	0.75	0.79	0.89		0.72	0.65	0.78	0.54	0.28	0.9	0.96	0.53	-0.03	0.85	-0.72	0.54	0.03	0.54	0.57	-0.52
Property Plant Equipment	0.8	0.78	0.9	0.97	0.99	0.97	0.96	0.74	0.72		0.94	0.81	0.47	-0.19	0.75	0.8	0.26	0.55	0.89	-0.75	0.88	-0.04	0.8	0.91	-0.86
Net Receivables	0.74	0.71	0.89	0.93	0.95	0.93	0.92	0.67	0.65	0.94		0.75	0.55	-0.29	0.7	0.74	0.25	0.46	0.83	-0.76	0.91	0.02	0.76	0.89	-0.9
Total Current Assets	0.95	0.9	0.75	0.82	0.83	0.88	0.78	0.89	0.78	0.81	0.75		0.53	-0.24	0.65	0.92	0.43	0.45	0.92	-0.66	0.72	0.0	0.78	0.75	-0.68
Short Term Debt	0.61	0.63	0.54	0.5	0.53	0.46	0.48	0.52	0.54	0.47	0.55	0.53		0.05	0.38	0.62	0.01	0.18	0.62	-0.51	0.39	-0.2	0.3	0.38	-0.35
Common Stock	-0.03	0.11	0.03	-0.07	-0.14	-0.2	-0.05	0.04	0.28	-0.19	-0.29	-0.24	0.05		0.37	0.08	0.22	-0.58	-0.15	-0.1	-0.5	0.01	-0.44	-0.47	0.54
Current Deferred Revenue	0.78	0.82	0.87	0.86	0.79	0.78	0.85	0.78	0.9	0.75	0.7	0.65	0.38	0.37		0.84	0.54	-0.03	0.74	-0.83	0.52	0.15	0.47	0.54	-0.49
Good Will	0.98	0.98	0.85	0.87	0.84	0.85	0.84	0.93	0.96	0.8	0.74	0.92	0.62	0.08	0.84		0.48	0.19	0.94	-0.76	0.64	0.03	0.67	0.68	-0.61
Deferred Long Term Liab	0.38	0.4	0.51	0.38	0.28	0.4	0.43	0.36	0.53	0.26	0.25	0.43	0.01	0.22	0.54	0.48		-0.15	0.23	-0.41	0.11	0.13	0.02	0.08	-0.1
Net Tangible Assets	0.27	0.22	0.25	0.38	0.5	0.48	0.36	0.21	-0.03	0.55	0.46	0.45	0.18	-0.58	-0.03	0.19	-0.15		0.39	-0.13	0.54	-0.33	0.59	0.62	-0.52
Long Term Debt Total	0.96	0.94	0.83	0.9	0.91	0.89	0.86	0.9	0.85	0.89	0.83	0.92	0.62	-0.15	0.74	0.94	0.23	0.39		-0.73	0.79	0.0	0.82	0.85	-0.77
Capital Surpluse	-0.7	-0.69	-0.87	-0.84	-0.8	-0.81	-0.86	-0.61	-0.72	-0.75	-0.76	-0.66	-0.51	-0.1	-0.83	-0.76	-0.41	-0.13	-0.73		-0.53	-0.34	-0.42	-0.54	0.5
Long Term Investments	0.68	0.63	0.72	0.84	0.87	0.85	0.78	0.67	0.54	0.88	0.91	0.72	0.39	-0.5	0.52	0.64	0.11	0.54	0.79	-0.53		-0.08	0.79	0.92	-0.99
Short Long Term Debt	-0.01	-0.05	0.09	0.01	-0.03	0.01	0.05	-0.03	0.03	-0.04	0.02	0.0	-0.2	0.01	0.15	0.03	0.13	-0.33	0.0	-0.34	-0.08		-0.11	-0.1	0.08
Cash And Equivalents	0.75	0.69	0.58	0.74	0.77	0.76	0.68	0.69	0.54	0.8	0.76	0.78	0.3	-0.44	0.47	0.67	0.02	0.59	0.82	-0.42	0.79	-0.11		0.92	-0.81
Net Invested Capital	0.73	0.68	0.74	0.85	0.88	0.85	0.82	0.66	0.57	0.91	0.89	0.75	0.38	-0.47	0.54	0.68	0.08	0.62	0.85	-0.54	0.92	-0.1	0.92		-0.94
Capital Stock	-0.65	-0.59	-0.7	-0.82	-0.83	-0.82	-0.77	-0.62	-0.52	-0.86	-0.9	-0.68	-0.35	0.54	-0.49	-0.61	-0.1	-0.52	-0.77	0.5	-0.99	0.08	-0.81	-0.94

Click cells to compare fundamentals

About Elevance Health Financial Statements

Elevance Health investors use historical fundamental indicators, such as Elevance Health's Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elevance Health. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	182.11	191.21
Tangible Book Value Per Share	4.64	3.94

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elevance Stock Analysis

When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC